MAUREEN BONNELL: Open Payments
NPI 1164201737 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 11 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $173 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $86 |
| ABBVIE INC. | 3 | $80 |
| Exact Sciences Corporation | 3 | $71 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Organon LLC | 1 | $19 |
Products named: INGREZZA, VRAYLAR, Cologuard Collection Kit, The Cologuard Plus Collection Kit, SHINGRIX, NEXPLANON, MAVYRET.
Industry payments across PA — which companies pay providers there.
